↓ Skip to main content
What is this page? Embed badge

A single-arm phase II clinical trial of anlotinib combined with chemotherapy for the treatment of metastatic triple-negative breast cancer

Overview of attention for article published in Frontiers in oncology, April 2023
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
1 news outlet
twitter
1 X user

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
7 Mendeley
Summary News X Dimensions citations
So far, Altmetric has seen 1 news story.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.

This page is provided by Altmetric.